GlassScriptPhysician profile
Jordan Patrick Dau
NPI 1104206325
$76,994.26
in general payments reported to CMS, 2019-2025
19 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $572 · 2021: $1,243 · 2022: $3,747 · 2023: $18K · 2024: $24K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $20K · Food and Beverage: $5,852 · Consulting Fee: $610 · Entertainment: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,805.00 |
| Travel and Lodging | $20,468.90 |
| Food and Beverage | $5,852.37 |
| Consulting Fee | $610.00 |
| Entertainment | $117.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $72,925.29 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $1,283.58 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb Americas INC. | $535.67 | 2022-2024 | Infuse |
| Abb Con-Cise Optical Group LLC | $361.14 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $300.81 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $261.47 | 2019-2021 | |
| Optos, INC. | $207.29 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lombart Brothers, INC. | $171.10 | 2024-2025 | Opd-III |
| Lumenis Be INC | $144.90 | 2024 | Optilight |
| Glaukos Corporation | $142.42 | 2021 | |
| Lkc Technologies, INC. | $125.98 | 2023 | |
| Abbvie INC. | $119.25 | 2022 | |
| Kala Pharmaceuticals, INC. | $115.19 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $87.70 | 2024 | Tecnis Iol, Tecnis Simplicity |
| Optovue, INC. | $78.77 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Plexus Optix, INC. | $44.28 | 2021 | |
| Heru, INC. | $35.46 | 2022 | |
| Notal Vision, INC. | $31.10 | 2025 | Foresee Home |
| Allergan, INC. | $22.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Dau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.